Biology Reference
In-Depth Information
Burnouf C, Pruniaux MP, Szilagy CM (1998) Phosphodiesterase 4 inhibitors. Ann Rev Med Chem
33:91-109
Calverley PMA, Sanchez-Toril F, McIvor A, Teichman P, Bredenbroker D, Fabbri LM (2007)
Effect of one year treatment with roflumilast in severe chronic obstructive lung disease.
Am J Respir Crit Care Med 176:151-161
Calverley PMA, Rabe KF, Goehring U-M, Kristiansen S, Fabbri LM, Martinez FJ (2009)
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomized clinical
trials. Lancet 374:684-695
Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K,
Yates JC, Calverley PM (2008) Effect of pharmacotherapy on rate of decline of lung function
in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit
Care Med 178:332-338
Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC (2002)
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 57:
226-230
Chaouat A, Naeije R, Weitzenblum E (2008) Pulmonary hypertension in COPD. Eur Respir J 32:
1371-1385
Charan NB (2001) Does sildenafil also improve breathing? Chest 120:305-306
Chockalingam A, Gnanavelu G, Venkatesan S, Elangovan S, Jagannathan V, Subramaniam T,
Alagesan R, Dorairajan S (2005) Efficacy and optimal dose of sildenafil in primary pulmonary
hypertension. Int J Cardiol 99:91-95
Clark AR (2007) Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endo-
crinol 275:79-97
Clarke DL, Belvisi MG, Smith SJ, Hardaker E, Yacoub MH, Meja KK, Rewton R, Slater DM,
Giembycz MA (2005a) Prostanoid receptor expression by human airways smooth muscle cells
and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol. 288:
L238-L250
Clarke DL, Belvisi MG, Hardaker E, Newton R, Giembycz MA (2005b) E-Ring 8-isoprostanes are
agonists at EP
2
- and EP
4
- prostanoid receptors on human airways smooth muscle cells and
regulate the release of colony-stimulating factors by activating cAMP-dependent protein
kinase. Mol Pharmacol. 67:383-393
Cordova C, Musca A, Violi F, Alessandri C, Perrone A, Balsano F (1985) Platelet hyperfunction in
patients with chronic airways obstruction. Eur J Respir Dis 66:9-12
Dahlman-Wright K, Wright A, Gustafsson JA, Carlstedt-Duke J (1991) Interaction of the gluco-
corticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment
of five amino acids. J Biol Chem 266:3107-3112
De Bosscher K, Vanden Berghe W, Haegeman G (2003) The interplay between the glucocorticoid
receptor and nuclear factor-
k
B or activator protein-1: molecular mechanisms for gene repres-
sion. Endocr Rev 24:488-522
Diefenbacher M, Sekula S, Heilbock C, Maier JV, Litfin M, van Dam H, Castellazzi M, Herrlich P,
Kassel O (2008) Restriction to
Fos
family members of Trip6-dependent coactivation and
glucocorticoid receptor-dependent transrepression of activator protein-1. Mol Endocrinol 22:
1767-1780
Doherty AM (1999) Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Curr Opin
Chem Biol 3:466-473
Dong H, Zitt C, Auriga C, Hatzelmann A, Epstein PM (2010) Inhibition of PDE3, PDE4 and PDE7
potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM
T leukemic cells. Biochem Pharmacol 79:321-329
Dunnill MS, Massarella GR, Anderson JA (1969) A comparison of the quantitative anatomy of the
bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema.
Thorax 24:176-179
Duplantier AJ, Biggers MS, Chambers RJ, Cheng JB, Cooper K, Damon DB, Eggler JF,
Kraus KG, Marfat A, Masamune H, Pillar JS, Shirley JT, UmLand JP, Watson JW (1996)
